Clinical Trials Directory

Trials / Completed

CompletedNCT00188006

Complement Activation and Central Nervous System Injury After Coronary Artery Surgery

Biocompatible Cardiopulmonary Bypass and Neuropsychological Outcome After Coronary Artery Bypass Surgery

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
Sponsor
University Hospital, Angers · Other Government
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

The impact of the postoperative inflammatory response on the central nervous system after cardiac surgery is uncertain. The goal of this study was to evaluate the role of complement activation on cellular brain injury and neurological functioning in patients undergoing coronary artery surgery. In addition, the effect of complement activation on the cerebral vasomotricity was assessed. Because receptors to activated complement are present on astrocytes, the heparin-coated cardiopulmonary bypass that reduces complement activation should minimize these postoperative neurological adverse events. Heparin-coating might also influence blood flow velocity in cerebral arteries postoperatively if complement activation mediates cardiopulmonary bypass induced cerebral vasomotor dysfunction.

Detailed description

Closed cardiopulmonary bypass and controlled suctions of pericardial shed blood were standardized in all patients. Bedside transcranial Doppler examination served to evaluate the development of cerebral vasomotor dysfunction in a subgroup of patients.

Conditions

Interventions

TypeNameDescription
DEVICEheparin-coated cardiopulmonary bypass

Timeline

First posted
2005-09-16
Last updated
2005-09-16

Source: ClinicalTrials.gov record NCT00188006. Inclusion in this directory is not an endorsement.